UBS ASSET MANAGEMENT AMERICAS LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 134 filers reported holding ANIKA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$210,130,000
-9.6%
8,829
-15.2%
0.00%
Q2 2022$232,329,000
-51.9%
10,409
-45.9%
0.00%
Q1 2022$483,066,000
-29.9%
19,2380.0%0.00%
Q4 2021$689,297,000
-15.8%
19,2380.0%0.00%
Q3 2021$818,770,000
+18.3%
19,238
+20.4%
0.00%
Q2 2021$691,991,000
+2.5%
15,985
-3.4%
0.00%
Q1 2021$674,787,000
-9.9%
16,5430.0%0.00%
Q4 2020$748,736,000
+27.9%
16,5430.0%0.00%
Q3 2020$585,457,000
+75.8%
16,543
+87.4%
0.00%
Q2 2020$333,118,000
-27.0%
8,829
-44.1%
0.00%
Q1 2020$456,314,000
-46.6%
15,784
-4.1%
0.00%
-100.0%
Q4 2019$853,762,000
-1.8%
16,466
+4.0%
0.00%0.0%
Q3 2019$869,073,000
+222.5%
15,833
+138.6%
0.00%
Q2 2019$269,514,000
+16323.8%
6,635
+20006.1%
0.00%
Q1 2018$1,641,000
-7.8%
330.0%0.00%
Q4 2017$1,779,000
-7.1%
330.0%0.00%
Q3 2017$1,914,000
+17.6%
330.0%0.00%
Q2 2017$1,628,000
+519.0%
33
-99.4%
0.00%
Q3 2016$263,000
-10.8%
5,5000.0%0.00%
Q2 2016$295,000
+19.9%
5,5000.0%0.00%
Q1 2016$246,000
+17.1%
5,5000.0%0.00%
Q4 2015$210,000
-1.9%
5,500
+5.8%
0.00%
Q1 2015$214,000
-3.6%
5,200
+8.3%
0.00%
Q2 2014$222,0004,8000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Caligan Partners LP 591,675$17,513,58014.58%
Trigran Investments, Inc. 1,564,541$46,310,4134.64%
DIKER MANAGEMENT LLC 22,458$664,7570.77%
Virtus Fund Advisers, LLC 3,490$103,3040.74%
Portolan Capital Management 207,900$6,153,8400.61%
Virtus Investment Advisers, Inc. 16,086$476,1460.32%
Ranger Investment Management 140,205$4,150,0680.31%
BOOTHBAY FUND MANAGEMENT, LLC 367,510$10,878,2960.25%
Riverwater Partners LLC 9,778$289,4290.25%
Legato Capital Management LLC 7,556$223,6580.04%
View complete list of ANIKA THERAPEUTICS INC shareholders